HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome [Phase 1]
A Phase 1 trial investigates underlying abnormalities in fat and muscle that lead to lipodystrophy in HIV infection, with insulin resistance…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy [Phase 4]
Phase 4 clinical trial investigating how and why lipodystrophy develops in people with HIV infection on antiretroviral therapy; the study ha…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects [NA]
This document reports a completed clinical trial evaluating cognitive behavioral therapy to reduce adverse effects of antiretroviral therapy…
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy [Phase 3]
A Phase 3 trial evaluating injections of polyacrylamide hydrogel for HIV-associated lipodystrophy has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients [Phase 4]
Phase 4 study assessing immune responses to the influenza A H1N1/09 vaccine in high-risk patients, including those with HIV infection and rh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir [Phase 3]
A Phase 3 trial compared once-daily darunavir/ritonavir 800/100 mg with a triple combination darunavir/ritonavir regimen in HIV infection; r…
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years [Phase 2]
This completed Phase 2 study evaluated an investigational regimen that includes marketed HIV drugs in pediatric participants aged 2 to 18 ye…
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
This report provides a pharmaco-epidemiological overview of patients treated with Aptivus (tipranavir) in real-world market use and assesses…
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Pioglitazone to Treat Fatty Liver in People With HIV Infection [Phase 2]
Phase 2 study evaluating pioglitazone for hepatic steatosis in people with HIV was completed, and results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen [Phase 3]
A Phase 3 trial assessed switching virologically suppressed HIV-1 patients from a first protease inhibitor–based regimen to an efavirenz-bas…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
The document reports a completed clinical trial evaluating Chembio's DPP HIV 1/2 Test and HIV 1/2 Stat Pak Test using oral fluid, with resul…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) [Phase 1]
A Phase 1 clinical trial evaluating an HIV vaccine (gp120/NefTat/AS02A) in individuals with chronic HIV-1 infection on HAART has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients [Phase 4]
A Phase 4 clinical trial is evaluating maraviroc in combination with raltegravir and darunavir/ritonavir for adults with HIV-1 who have trip…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals. [NA]
A completed clinical trial evaluated the impact of soluble fiber on triglyceride levels and immune profile in HIV-positive individuals.
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
This completed pilot clinical trial examined the effect of minocycline on HIV-1 infection in cerebrospinal fluid.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen [Phase 3]
A Phase IIIb study comparing two boosted protease inhibitor-based HAART regimens in HIV-infected patients experiencing their first virologic…
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir [Phase 3]
Phase 3 trial evaluating switching HIV patients with undetectable viral load and abnormal lipids to the fixed-dose combination of atazanavir…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark
Clinical trial update on raltegravir treatment for HIV-infected patients failing HAART in Denmark; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: DDI HV (ATV - Merck) [Phase 1]
Phase 1 clinical trial update for atazanavir (ATV) related to HIV infections; the study status is listed as completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Phase 4]
A Phase 4 clinical trial evaluating a combination of tenofovir disoproxil fumarate and emtricitabine in HIV-1 patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects [Phase 3]
Phase 3 study comparing once-daily versus twice-daily lopinavir/ritonavir in ART-experienced HIV-1 infected subjects coadministered with nuc…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya [NA]
This completed clinical trial evaluated whether SMS reminders could improve adherence to antiretroviral therapy in Western Kenya.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects [Phase 2]
Phase 2 trial assessing antiviral activity and safety of two doses of mifepristone in HIV-1 infected subjects.
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication [Phase 4]
Phase 4 trial comparing VircoTYPE HIV-1 testing with expert interpretation of genotypic results to control HIV infection.
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* [Phase 2]
Phase 2 safety and efficacy study of Bevirimat monotherapy in HIV treatment-experienced patients for 2 weeks has completed.